Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies - Authors' reply

Research output: Contribution to journalLetterResearchpeer-review

  1. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities

    Research output: Contribution to journalReviewResearchpeer-review

  2. Is oropharyngeal sampling a reliable test to detect SARS-CoV-2?

    Research output: Contribution to journalLetterResearchpeer-review

  3. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming

    Research output: Contribution to journalLetterResearchpeer-review

  2. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalLancet Infectious Diseases
Volume21
Issue number5
Pages (from-to)e119
ISSN1473-3099
DOIs
Publication statusPublished - May 2021

    Research areas

  • Antibodies, Viral, COVID-19, Cohort Studies, Cross Reactions, Denmark, Humans, SARS-CoV-2

ID: 61696232